LG
| |
Logos Global Management LP13F | |
| Logos Global Management LP | |
| Last update 2024-11-14 | 55 Stocks (14 new) |
| Value $927.00 Mil | Turnover 26 % |
| Portfolio Report | |
Logos Global Management LP Top Holdings of 2024-09-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDYA | IDEAYA Biosciences Inc | 2,100,000 | 66528.000 | -38.24% | 7.180 | -1.84% | 2.430 | -20.43% | -6.50% | 2076.956 | Biotechnology | |
GPCR | Structure Therapeutics Inc | 1,250,000 | 54862.500 | -52.83% | 5.920 | -2.22% | 2.190 | -35.00% | -6.86% | 1446.405 | Biotechnology | |
RVMD | Revolution Medicines Inc | 1,200,000 | 54420.000 | -50.00% | 5.870 | -1.88% | 0.710 | -15.60% | -4.48% | 7720.755 | Biotechnology | |
IRON | Disc Medicine Inc | 935,000 | 45945.900 | -49.46% | 4.960 | -1.67% | 3.140 | +24.81% | -6.55% | 1762.997 | Biotechnology | |
JANX | Janux Therapeutics Inc | 1,000,000 | 45430.000 | -33.33% | 4.900 | -0.85% | 1.910 | -0.97% | -12.66% | 2741.670 | Biotechnology | |
OLMA | Olema Pharmaceuticals inc | 3,208,875 | 38313.970 | -50.00% | 4.130 | -1.41% | 5.600 | -54.84% | -13.55% | 374.187 | Biotechnology | |
PCVX | Vaxcyte Inc | 300,000 | 34281.000 | New Holding | 3.700 | +3.70% | 0.240 | -27.35% | -0.95% | 10105.531 | Biotechnology | |
IMVT | Immunovant Inc | 1,100,000 | 31361.000 | -4.35% | 3.380 | -0.05% | 0.750 | -21.55% | -5.21% | 3446.503 | Biotechnology | |
CLDX | Celldex Therapeutics Inc | 900,000 | 30591.000 | New Holding | 3.300 | +3.30% | 1.360 | -17.96% | -3.64% | 1615.482 | Biotechnology | |
OCUL | Ocular Therapeutix Inc | 3,500,000 | 30450.000 | -66.02% | 3.290 | -1.88% | 2.240 | -10.95% | -3.86% | 1290.755 | Biotechnology |
Logos Global Management LP's Historical Top Holdings Breakdowns
Logos Global Management LP's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
CYTK | Cytokinetics Inc | 2024-03-31 | Reduce | -11.88% | 63.75 ($77.34) 108.06 | $46.62 | -39.72% | Reduce -93.85% | 100,000 | -1,525,000 | |
| ISEE | IVERIC bio Inc | 2023-06-30 | Sold Out | -5.29% | 24.33 ($35.12) 39.63 | $39.95 | 13.75% | Sold Out | 0 | -1,520,000 | |
ARGX | argenx SE | 2024-03-31 | Sold Out | -5.15% | 356.95 ($387.4) 413.29 | $656.26 | 69.40% | Sold Out | 0 | -145,000 | |
ARGX | argenx SE | 2023-12-31 | New Buy | +5.15% | 338.91 ($465.95) 506.01 | $656.26 | 40.84% | New holding | 145,000 | 145,000 | |
IMCR | Immunocore Holdings PLC | 2024-06-30 | Sold Out | -4.73% | 33.78 ($51) 63.75 | $30.40 | -40.39% | Sold Out | 0 | -900,000 | |
RCKT | Rocket Pharmaceuticals Inc | 2023-09-30 | Add | +4.72% | 15.07 ($18.18) 24.05 | $11.14 | -38.72% | Add 690% | 1,975,000 | 1,725,000 | |
ARGX | argenx SE | 2024-06-30 | New Buy | +4.69% | 356.01 ($382.76) 451.55 | $656.26 | 71.45% | New holding | 270,000 | 270,000 | |
ARGX | argenx SE | 2024-09-30 | Sold Out | -4.69% | 434.22 ($505.35) 552.56 | $656.26 | 29.86% | Sold Out | 0 | -270,000 | |
APLS | Apellis Pharmaceuticals Inc | 2024-09-30 | Sold Out | -4.34% | 28.84 ($37.03) 41.15 | $27.44 | -25.90% | Sold Out | 0 | -2,800,000 | |
SRPT | Sarepta Therapeutics Inc | 2024-03-31 | New Buy | +4.19% | 93.7 ($122.5) 141.53 | $124.79 | 1.87% | New holding | 400,000 | 400,000 |
Logos Global Management LP Total Holding History ($B)
Logos Global Management LP's Asset Allocation
Logos Global Management LP Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Logos Global Management LP's Hypothetical Growth since 2024-09-30
Logos Global Management LP's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Logos Global Management LP's Holdings Heat Map
Size field:
Logos Global Management LP's Holdings Bubble Chart
Logos Global Management LP News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers